Diabetic patients who take anti-diabetic drugs – known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.
KAUST researchers uncover LINE-1 RNA’s role in triggering bone repair
Around half of the human genome is composed of DNA fragments originating from ancient viruses. These “transposable elements” (TEs) are now known to play various